// App-Quantinova.ai

3555 : Romiplostim For Thrombocytopenia in Patients with Hepatitis C (HCV)-Associated Liver Disease: Preliminary Report Of An Ongoing Clinical Trial

Researchers

Presenter

  • Howard Liebman

Principal Investigators

  • Laurie Hornor

  • Tse-Ling Fong

  • Casey -Connell

  • Ilene C Weitz

Medical Centers

  • Jane Anne Nohl Division of Hematology, Keck School Of Medicine of USC, Los Angeles, CA

  • Rheumatology, UCLA School of Medicine, Los Angeles, CA

  • Jane Anne Nohl Division of Hematology Center for the Study of Blood Diseases, Los Angeles, CA

  • Gastroenterology-Hepatology, Keck School of Medicine, Los Angeles, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Gastroenterology (GU)

Disease

  • Thrombocytopenia

  • Hepatitis C

  • Venous thrombosis

  • Cirrhosis

Biomarkers

  • N/A

Drug/Treatment

  • PEG-interferon

  • Romiplostim

  • LMW heparin

  • Interferon

  • Ribavirin

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved